Medivizor

Title of notification

Here comes the notification
X
 
icon
icon
rheumatoid arthritis | Research | Treatment | 10 pages | source: Annals of the rheumatic diseases | Added Jun 15, 2020

Pharmacological treatment of rheumatoid arthritis – an updated review

This study reviewed the effectiveness of drugs used to treat rheumatoid arthritis (RA). 

icon
icon
diabetes mellitus | Research | Lifestyle | 10 pages | source: Diabetes Research and Clinical Practice | Added Jun 15, 2020

Can diet control blood pressure in patients with diabetes?

This study reviewed dietary approaches to lower blood pressure in patients with type 2 diabetes (T2D). It found that several diets including low-sodium, high-fiber, DASH, low-protein, and vegan were effective in reducing blood pressure in patients with T2D.

icon
rheumatoid arthritis | Research | 10 pages | source: Phytotherapy research : PTR | Added Jun 12, 2020

Does saffron supplementation improve rheumatoid arthritis disease activity?

This study investigated if saffron supplementation (SS) improves rheumatoid arthritis (RA) symptoms. They found that SS reduced disease activity (DA) in patients with RA.

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added Jun 12, 2020

How effective and safe is non-insulin drug evogliptin for patients with type 2 diabetes?

This study compared the effectiveness and safety of evogliptin (Suganon) to another non-insulin drug, linagliptin (Tradjenta), in patients with type 2 diabetes (T2D). The results showed that evogliptin was as safe and effective at reducing patients’ blood glucose levels as linagliptin.

icon
icon
rheumatoid arthritis | Research | Lifestyle | 10 pages | source: PLOS ONE | Added Jun 10, 2020

Does vegetable and seafood intake affect disease activity in rheumatoid arthritis?

This study investigated the effect of vegetable and seafood intake in patients with rheumatoid arthritis (RA). 

They found that high vegetable and seafood intake may be associated with lower disease activity (LDA).

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: International Journal of Cardiology | Added Jun 10, 2020

Can novel non-insulin therapies for patients with type 2 diabetes prevent heart disease?

This study examined how frequent heart disease is among patients taking different non-insulin medications for type 2 diabetes (T2D). The results showed that certain medications significantly reduced the risk of patients developing heart disease and other complications of T2D.

icon
rheumatoid arthritis | Research | 10 pages | source: International journal of clinical practice | Added Jun 08, 2020

Garlic supplementation and inflammation in rheumatoid arthritis – are there any benefits?

This study investigated if garlic supplementation improves rheumatoid arthritis (RA) symptoms and inflammation. 

They found that garlic supplements improved pain and quality of life (QoL) in these patients. 

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added Jun 08, 2020

Can exenatide once weekly reduce diabetic kidney damage?

This study looked at exenatide (Byetta) for patients with type 2 diabetes (T2D) and kidney damage. It found that exenatide may reduce kidney damage compared to other diabetes treatments.

icon
icon
rheumatoid arthritis | Research | Treatment | 10 pages | source: Arthritis Research & Therapy | Added Jun 06, 2020

Long-term safety and effectiveness of peficitinib for rheumatoid arthritis

This study investigated the long-term safety and effectiveness of peficitinib (Smyraf) in rheumatoid arthritis (RA). They found that this treatment lowered disease activity (DA) and was well tolerated. 

icon
icon
diabetes mellitus | Research | Treatment | 10 pages | source: Diabetes, Obesity and Metabolism | Added Jun 06, 2020

Can iGlarLixi improve blood glucose control in patients receiving basal insulin?

This study looked at whether iGlarLixi (Soliqua), a combination of long-acting insulin glargine (Lantus) and lixisenatide (Lyxumia), can improve glucose control for patients with type 2 diabetes (T2D) uncontrolled with long-acting insulin alone. It found that iGlarLixi improved overall and after-meal blood sugar control compared to insulin alone.

View

Conditions

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?